Vegf inhibitors for the treatment of malignant pleural effusion

Details Vegf inhibitors for the treatment of malignant pleural effusion Vegf inhibitors for the treatment of malignant pleural effusion

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61K 38/18 (2006.01) A61P 11/00 (2006.01) A61P 35/00 (2006.01) C07K 14/71 (2006.01)

Patent

CA 2568534

Methods for treating a human patient suffering from malignant pleural effusion by administering an effective amount of a vascular endothelial growth factor (VEGF) inhibitor to the human patient. The VEGF inhibitor is a VEGF trap protein comprising a dimeric protein having two fusion polypeptides having the sequence of SEQ ID NO:2.

Méthode de traitement d'un patient souffrant d'un épanchement pleural malin, qui consiste à administer à ce patient une dose efficace d'un inhibiteur du facteur de croissance de l'endothélium vasculaire (VEGF). L'inhibiteur VEGF est une protéine de piégeage comprenant une protéine dimère à deux polypeptides de fusion à séquence SEQ ID NO:2.

Affiliated with

Also associated with

Rating

Vegf inhibitors for the treatment of malignant pleural effusion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vegf inhibitors for the treatment of malignant pleural effusion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vegf inhibitors for the treatment of malignant pleural effusion will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2020726